Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,295
Closed -$248K 57
2024
Q2
$248K Sell
10,295
-8,924
-46% -$219K 0.06% 86
2024
Q1
$520K Sell
19,219
-1,162
-6% -$33K 0.13% 84
2023
Q4
$565K Sell
20,381
-29,247
-59% -$760K 0.16% 80
2023
Q3
$1.39M Buy
49,628
+1,944
+4% +$57K 0.42% 79
2023
Q2
$1.49M Buy
47,684
+749
+2% +$22.7K 0.43% 79
2023
Q1
$1.32M Buy
46,935
+1,294
+3% +$35.3K 0.41% 81
2022
Q4
$1.19M Buy
45,641
+4,610
+11% +$110K 0.44% 77
2022
Q3
$916K Sell
41,031
-338
-0.8% -$8.79K 0.35% 83
2022
Q2
$1.23M Buy
+41,369
New +$1.19M 0.47% 77
2022
Q1
Sell
-38,903
Closed -$992K 100
2021
Q4
$992K Buy
38,903
+6,958
+22% +$183K 0.32% 86
2021
Q3
$949K Buy
+31,945
New +$902K 0.28% 90

Other funds holding ALKS

Paradiem's ALKS Position: Q3 2024 in Review

Paradiem sold out of Alkermes (ALKS) in Q3 2024, closing a stake of 10,295 shares — an estimated $248K sold.

Paradiem first reported a position in ALKS in Q3 2021 and held it in 11 quarters. The position peaked at $1.49M in Q2 2023. 338 funds tracked by Wall St. Rank hold ALKS as of Q3 2024.

  • Paradiem reported no remaining Alkermes position as of Q3 2024 after selling out during the quarter.
  • Paradiem sold 10,295 Alkermes shares in Q3 2024, an estimated $248K.
  • Paradiem first reported a position in Alkermes in Q3 2021 and held it in 11 quarters.
  • Paradiem's Alkermes position peaked at $1.49M in Q2 2023.
  • 338 funds tracked by Wall St. Rank held Alkermes as of Q3 2024.

Based on Paradiem's 13F filing for Q3 2024, filed 24 Oct 2024.